Veterinary Satisfaction Trial with Injectable Cefovecin Sodium in Cats as Treatment for Skin Infections Including Wounds and Abscesses
Cefovecin sodium is an injectable cephalosporin antibiotic, indicated for use as a treatment for susceptible skin infections including wounds and abscesses in cats, provides clinical efficacy for 14 days in a single, one-time administration, and is newly available for clinical practice in India.
The objective of this study was to evaluate veterinary satisfaction based on clinical assessment of response to treatment with cefovecin sodium in client-owned cats.
Twenty-two (22) cats of various breeds, ranging in age from 5 months to 4 years, in 10 different veterinary practices in India representing all regions of the country were administered 8 mg/kg cefovecin sodium subcutaneously as therapy for skin infections including wounds and abscesses resulting from dog, cat, and snake bites, amongst other causes. The date of examination/treatment, signalment, and appearance of the cat, location of lesion(s), tentative diagnosis, and clinical reassessment/outcome were recorded. The veterinarian was also asked to provide visualization of the outcome through high image resolution digital photographs.
Outcomes were as follows: 22 cases classified as either excellent (2) or satisfying (20).
The overall satisfaction rate in this sample of cats from India was 100.00% (22/22), calculated by pooling results from the outcomes of excellent and satisfying; no case was assessed as unsatisfying or indifferent. This study demonstrates the usefulness of cefovecin sodium as a treatment for skin infections including wounds and abscesses in cats, as assessed by clinical response through the attending veterinarian.